Holcombe Discusses Colorectal Cancer in Vermont Public Interview

Burlington, Vt and Lake Champlain at dusk

2023 External Advisory Board


Name	Title
Chair
Roy Jensen, MD	Professor, Pathology and Laboratory Medicine Professor, Cancer Biology Director, The University of Kansas Cancer Center William R. Jewell, M.D. Distinguished Kansas Masonic Professor of Cancer Research and Director, Kansas Masonic Cancer Research Institute, University of Kansas Medical Center
Programs and Shared Resources
Stanton Gerson, MD	Dean, School of Medicine Sr. Vice President for Medical Affairs (Immediate past) Acting Director, Case Comprehensive Cancer Center Director, National Center for Regenerative Medicine Professor, Department of Medicine Professor, Department of Environmental Health Sciences Member, Immune Oncology Program, Case Comprehensive Cancer Center
Steven D. Leach, MD	Preston T. and Virginia R. Kelsey Professr Director, Dartmouth Cancer Center Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer
Martha Mims, MD, PhD	Professor, Medicine Chief, Hematology and Oncology Associate Director of Clinical Research Dan L Duncan Comprehensive Cancer Center Dan L Duncan Professorship, Baylor College of Medicine
Kathi Mooney, RN, PhD	Distinguished Professor, College of Nursing Co-Leader Cancer Control and Population Sciences, Huntsman Cancer Institute University of Utah
Joe W. Ramos, PhD, MPH	Director, CEO, Louisiana Cancer Research Center
Matthew D. Ringel, MD	Professor and Chair, Department of Molecular Medicine and Therapeutics Ralph W. Kurtz Chair Co-Leader Cancer Biology Program Co-Director Center for Cancer Engineering Deputy Director, Center for Clinical and Translational Sciences The Ohio State University Wexner Medical Center & OSU Comprehensive Cancer Center
Susan T. Vadaparampil, PhD, MPH	Associate Center Director for Community Outreach, Engagement & Equity Professor, Department of Health Outcomes and Behavior Director, Behavioral Oncology T32 Postdoctoral Training Program Moffitt Cancer Center
Administration
Melissa Fitzmaurice Neligan, MPH, CRA	Chief Administrative Officer UCLA Jonsson Comprehensive Cancer Center
Vermont E3 Participants
Emily Hallgren, PhD	Assistant Professor University of Arkansas for Medical Sciences - Northwest
Tianxiang "Sean" Hu, PhD	Assistant Professor Georgia Cancer Center

Holcombe Discusses Colorectal Cancer in Vermont Public Interview

April 17, 2024 by Lucy Gardner Carson

Randall Holcombe, M.D., M.B.A., director of the UVM Cancer Center, chief of the UVM Medical Center Division of Hematology/Oncology, and professor of medicine at the Larner College of Medicine

(APRIL 17, 2024) Randall Holcombe, M.D., M.B.A., director of the UVM Cancer Center, chief of the UVM Medical Center Division of Hematology/Oncology, and professor of medicine at the Larner College of Medicine, discussed colorectal cancer in a Vermont Public interview.

The third most common cancer for men and women in Vermont, colorectal cancer is the second leading cause of cancer-related death in the state, Holcombe said. But colorectal cancer is a preventable and highly treatable form of cancer—regular screenings can help detect it early and lead to higher survival rates.

“If it’s caught early and localized, then survival rate is about 80 percent at five years,” Holcombe said on Vermont Edition. “Unfortunately, if it’s found when it’s metastatic, or spread—that would be a Stage 4 cancer—then the five-year survival rate is only about 11 percent. So it makes a huge difference to try to catch the cancer early.”

Read full story at Vermont Public